Drug Type Small molecule drug |
Synonyms 2,6-Dimethoxy-1,4-benzoquinone |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC8H8O4 |
InChIKeyOLBNOBQOQZRLMP-UHFFFAOYSA-N |
CAS Registry530-55-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Shock, Septic | Preclinical | China | 20 Jun 2024 | |
Shock, Septic | Preclinical | China | 20 Jun 2024 |